441 related articles for article (PubMed ID: 23157581)
1. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
[TBL] [Abstract][Full Text] [Related]
2. Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years.
Mikaeloff Y; Rey E; Soufflet C; d'Athis P; Echenne B; Vallée L; Bouhours P; Grinspan A; Dulac O; Pons G; Chiron C
Epilepsia; 2004 Nov; 45(11):1448-52. PubMed ID: 15509246
[TBL] [Abstract][Full Text] [Related]
3. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures.
Novotny E; Renfroe B; Yardi N; Nordli D; Ness S; Wang S; Weber T; Kurland CL; Yuen E; Eerdekens M; Venkatraman L; Nye JS; Ford L
Neurology; 2010 Mar; 74(9):714-20. PubMed ID: 20089937
[TBL] [Abstract][Full Text] [Related]
5. Long-term open-label study of adjunctive topiramate in infants with refractory partial-onset seizures.
Puri V; Ness S; Sattaluri SJ; Wang S; Todd M; Yuen E; Eerdekens M; Nye JS; Manitpisitkul P; Shalayda K; Ford L
J Child Neurol; 2011 Oct; 26(10):1271-83. PubMed ID: 21673279
[TBL] [Abstract][Full Text] [Related]
6. A study of topiramate pharmacokinetics and tolerability in children with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Baldassarre JS; Reife RA
Pediatr Neurol; 1999 May; 20(5):339-44. PubMed ID: 10371378
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
[TBL] [Abstract][Full Text] [Related]
8. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
9. Topiramate pharmacokinetics in infants.
Glauser TA; Miles MV; Tang P; Clark P; McGee K; Doose DR
Epilepsia; 1999 Jun; 40(6):788-91. PubMed ID: 10368080
[TBL] [Abstract][Full Text] [Related]
10. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation.
Bialer M; Shekh-Ahmad T; Braun TL; Halvorsen MB
Epilepsia; 2013 Aug; 54(8):1444-52. PubMed ID: 23692553
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
12. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
Gidal BE; Ferry J; Majid O; Hussein Z
Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
[TBL] [Abstract][Full Text] [Related]
13. Topiramate: a new antiepileptic drug.
Privitera MD
Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
15. Low-dose topiramate in adults with treatment-resistant partial-onset seizures.
Guberman A; Neto W; Gassmann-Mayer C;
Acta Neurol Scand; 2002 Oct; 106(4):183-9. PubMed ID: 12225311
[TBL] [Abstract][Full Text] [Related]
16. Preliminary observations on topiramate in pediatric epilepsies.
Glauser TA
Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
[TBL] [Abstract][Full Text] [Related]
17. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
18. Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study.
Ramsay RE; Uthman B; Pryor FM; Rowan AJ; Bainbridge J; Spitz M; Sirven JI; Frederick TE
Epilepsia; 2008 Jul; 49(7):1180-5. PubMed ID: 18494791
[TBL] [Abstract][Full Text] [Related]
19. Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled study.
Mann D; Liu J; Chew ML; Bockbrader H; Alvey CW; Zegarac E; Pellock J; Pitman VW
Epilepsia; 2014 Dec; 55(12):1934-43. PubMed ID: 25377429
[TBL] [Abstract][Full Text] [Related]
20. Adaptive behavior outcomes in infants treated with adjunctive topiramate.
Ness S; Todd MJ; Wang S; Eerdekens M; Nye JS; Ford L
Pediatr Neurol; 2012 Jun; 46(6):350-8. PubMed ID: 22633629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
